|
|
Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A compound of the formula ##STR10## where (a) X.sup.1 is chlorine and X.sup.2 is methyl or RO--, or (b) X.sup.2 is RO-- and X.sup.1 is NR.sup.1 R.sup.2 ...
|
|
|
Nucleic acid probes immobilized on polystyrene surfaces
We claim: 1. An article of manufacture for use in a solution phase nucleic acid sandwich hybridization assay comprising a polystyrene surface having a polypeptide ...
|
|
|
Star polymers having multiple polyisobutylene arms emanating from a calixarene core, initiators therefor, and method for the synthesis thereof
What is claimed is: 1. A composition of matter comprising: a core component selected from the group consisting of a p-methoxy cumyl group and a calix?n!arene where n=4 ...
|
|
|
High molecular weight polymer-based prodrugs
The present invention addresses the shortcomings described above. In one aspect of the invention, compositions of formula (I) are provided: ##STR3## wherein: D is a ...
|
|
|
Non-antigenic branched polymer conjugates
OF THE INVENTION 1. POLYMER SUBSTITUENTS AND FORMULA (I) DEFINED The activated branched polymers of the present invention are preferably prepared from poly(alkylene ...
|
|
|
Substantially pure histidine-linked protein polymer conjugates
In one aspect, the present invention includes substantially pure protein-polymer conjugates. The conjugates include a protein, such as an alpha interferon, covalently ...
|
|
|
Crosslinked polymer compositions and methods for their use
The present invention discloses a crosslinked polymer composition comprising a first synthetic polymer containing two or more nucleophilic groups, and a second synthetic ...
|
|
|
Conjugation of polypeptides
OF THE INVENTION It is the object of the invention to provide polypeptide conjugates with reduced allergenicity. As described above it is well-known according to prior ...
|
|
|
High molecular weight polymer-based prodrugs
OF THE INVENTION A. THE PRODRUGS In most aspects of the invention, the prodrug compositions of the present invention contain hydrolyzable linkages between the polymer ...
|
|
|
Non-antigenic amine derived polymers and polymer conjugates
In one aspect of the invention, there are provided amine-based polymer intermediates having the formula: R--B (I) wherein (R) is a water-soluble, substantially non-...
|